查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1666179

全球医疗分析市场 - 2025 至 2033 年

Global Healthcare Analytics Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球医疗保健分析市场规模达到 297.3 亿美元，预计到 2033 年将达到 479.7 亿美元，在 2025-2033 年预测期内的复合年增长率为 5.4%。

医疗保健分析是一种分析大量医疗保健资料以改善决策和结果的方法。它使用描述性、预测性和规范性分析等工具将来自 EHR、医学影像和患者监测系统等来源的原始资料转换为可操作的见解。医疗保健分析可优化患者护理、提高营运效率、降低成本并支持基于证据的决策。它使用巨量资料、人工智慧和机器学习来改善结果同时最大限度地降低风险。

市场动态：

驱动因素与约束因素

医疗保健领域越来越多地采用数据驱动的决策

全球医疗保健分析市场的发展受到医疗保健产业日益采用数据驱动决策的推动。医疗保健组织（包括医院、付款人和製药公司）正在使用分析来提高营运效率、加强患者护理并降低成本。随着医疗保健资料量的不断增长，分析解决方案可以实现预测分析，以识别健康趋势、风险和治疗结果。这有助于医疗保健提供者做出明智的决策，从而获得更好的临床和财务结果。政府和医疗保健组织正在投资医疗保健数位化和资料基础设施，进一步支持医疗保健分析市场的成长。

例如，2024 年 8 月，领先的医疗保健 AI 公司 Innovaccer Inc. 推出了政府健康 AI 数据和分析平台 (GHAAP)，这是一个屡获殊荣的公共部门平台。该平台专注于医疗补助和公共卫生现代化，连续三年被 KLAS Research 和 Black Book 评为人口健康领域的顶级资料和分析平台。

资料隐私和安全问题

医疗保健分析解决方案通常涉及收集和处理大量患者资料，这可能导致资料外洩和未经授权的存取。这对患者的隐私和信任构成了严重风险。医疗保健组织必须遵守 HIPAA 和 GDPR 等严格的监管要求，这增加了资料管理的复杂性。这些法规要求采取强有力的安全措施，这可能会花费大量成本且耗费时间。因此，对病患资料安全性和保密性的担忧可能会阻碍医疗保健分析的广泛采用，尤其是在资料保护基础设施较不成熟的地区。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 医疗保健领域越来越多地采用数据驱动的决策
    • 限制
      • 资料隐私和安全问题
    • 机会
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：按组件

  • 软体
  • 服务

第 7 章：按类型

  • 描述性分析
  • 预测分析
  • 规范分析

第 8 章：按应用

  • 财务分析
  • 临床分析
  • 营运分析
  • 人口健康分析
  • 其他的

第 9 章：按最终用户

  • 医院和医疗保健提供者
  • 医疗付款人（保险公司）
  • 製药及生技公司
  • 政府组织

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • IBM Corporation
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • SAS Institute Inc.
  • McKesson Corporation
  • HR Insights
  • Siemens Healthineers
  • Oracle Corporation
  • Allscripts Healthcare Solutions, Inc.
  • Philips Healthcare
  • IQVIA
  • Flatiron Health
  • Similar data will be provided for each market player.
  • 健康催化剂
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • Verisk 分析
  • 奥姆尼系统
  • 将为每个市场参与者提供类似的资料。

第 13 章：附录

简介目录
Product Code: HCIT250

The Global Healthcare Analytics Market reached US$ 29.73 Billion in 2024 and is expected to reach US$ 47.97 Billion by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.

Healthcare Analytics is a method of analyzing large amounts of healthcare data to improve decision-making and outcomes. It uses tools like descriptive, predictive, and prescriptive analytics to transform raw data from sources like EHRs, medical imaging, and patient monitoring systems into actionable insights. Healthcare analytics optimizes patient care, enhances operational efficiency, reduces costs, and supports evidence-based decision-making. It uses big data, AI, and machine learning to improve outcomes while minimizing risks.

Market Dynamics: Drivers & Restraints

Increasing Adoption of Data-driven Decision Making in Healthcare

The Global Healthcare Analytics Market is driven by the growing adoption of data-driven decision making in the healthcare industry. Healthcare organizations, including hospitals, payers, and pharmaceutical companies, are using analytics to improve operational efficiencies, enhance patient care, and reduce costs. With the growing volume of healthcare data, analytics solutions enable predictive analysis to identify health trends, risks, and treatment outcomes. This helps healthcare providers make informed decisions, leading to better clinical and financial outcomes. Governments and healthcare organizations are investing in healthcare digitization and data infrastructure, further supporting the growth of the healthcare analytics market.

For instance, in August 2024, Innovaccer Inc., a leading healthcare AI company, has launched the Government Health AI Data and Analytics Platform (GHAAP), an award-winning platform for the public sector. The platform focuses on Medicaid and Public Health Modernization and has been ranked as the top data and analytics platform for Population Health by KLAS Research and Black Book three years in a row.

Data Privacy and Security Concerns

Healthcare analytics solutions often involve the collection and processing of large volumes of patient data, which can lead to data breaches and unauthorized access. This poses serious risks to patient privacy and trust. Healthcare organizations must comply with stringent regulatory requirements like HIPAA and GDPR, adding complexity to data management. These regulations require robust security measures, which can be costly and time-consuming. As a result, concerns over the security and confidentiality of patient data can hinder the widespread adoption of healthcare analytics, especially in regions with less mature data protection infrastructure.

Segment Analysis

The global healthcare analytics market is segmented based on Component, Type, Application, End User and Region.

Component:

Software segment is expected to dominate the Healthcare Analytics market share

The software segment holds a major portion of the Healthcare Analytics market share and is expected to continue to hold a significant portion of the Healthcare Analytics market share during the forecast period.

The Global Healthcare Analytics Market is dominated by software solutions that collect, process, and analyze vast amounts of healthcare data. These tools enable organizations to perform descriptive, predictive, and prescriptive analytics, providing insights to improve patient care, reduce operational costs, and enhance clinical decision-making. Key software solutions include EHR management tools, CDSS, and patient monitoring systems. As healthcare providers adopt data-driven strategies, software solutions are becoming indispensable in improving healthcare efficiency and patient outcomes, driving market growth.

For instance, in May 2024, Health Catalyst has launched Health Catalyst Ignite, a next-generation healthcare data and analytics ecosystem that combines best-in-class technologies, healthcare-specific data models, self-service tools, and industry expertise in a modern environment.

End User:-

Hospitals and Healthcare Providers segment is the fastest-growing segment in Healthcare Analytics market share

The hospitals and healthcare providers segment is the fastest-growing segment in the Healthcare Analytics market share and is expected to hold the market share over the forecast period.

The Hospitals & Healthcare Providers segment is driving the Global Healthcare Analytics Market due to the need to improve patient care, operational efficiency, and reduce costs. Healthcare providers are adopting analytics solutions to gain data-driven insights, optimize treatment pathways, and manage resources effectively. The rising prevalence of chronic diseases and growing patient population are driving the need for predictive and prescriptive analytics. The increasing volume of healthcare data from EHRs and medical devices is also driving the need for advanced data analytics tools. Population health management strategies are also driving market growth.

For instance, in October 2024, Growth.Health has launched the G1 Healthcare Data and Analytics Platform, a SaaS engine designed to provide unprecedented insights into the healthcare industry. The platform will be publicly unveiled at HLTH 2024 in Las Vegas, allowing professionals to better understand their customers and identify similar individuals.

Geographical Analysis

North America is expected to hold a significant position in the Healthcare Analytics market share

North America holds a substantial position in the Healthcare Analytics market and is expected to hold most of the market share due to high healthcare spending, and strong technological adoption. Also the region's well-established healthcare system and health tech ecosystem are fuelled by the widespread use of EHRs and cloud-based analytics solutions. The growing prevalence of chronic diseases and focus on value-based care are driving demand for efficient patient care and data management solutions. With supportive government initiatives and a favourable regulatory environment, North America is poised to continue its leadership role in the healthcare analytics market.

For instance, in January 2025, LexisNexis Risk Solutions has launched research-ready real-world datasets to accelerate research timelines, reduce costs, and enable more equitable analyses. These datasets are blended, expertly determined, and certified using referential-based tokenization. This simplifies data enrichment and cohort definition, allowing research teams to benchmark with comparator cohorts. These datasets integrate into clinical research workflows, generating real-world evidence to accelerate innovation and speed-to-market.

Europe is growing at the fastest pace in the Healthcare Analytics market

Europe holds the fastest pace in the Healthcare Analytics market and is expected to hold most of the market share due to government-backed digitization initiatives, increasing demand for data-driven healthcare solutions, and an aging population. Countries are investing in eHealth and health IT systems to improve healthcare delivery, reduce inefficiencies, and enhance patient outcomes. Telemedicine and remote patient monitoring technologies are also contributing to the demand for analytics. Strong regulatory frameworks like GDPR prioritize data privacy and security, making Europe a strong contributor to the market.

Competitive Landscape

The major global players in the Healthcare Analytics market include IBM Corporation, SAS Institute Inc. McKesson Corporation, HR Insights, Siemens Healthineers, Oracle Corporation, Allscripts Healthcare Solutions, Inc., Philips Healthcare, IQVIA, Flatiron Health and among others.

Key Developments

  • In May 2024, mPulse, a leader in conversational AI and digital engagement solutions for healthcare, reported strong growth in Q1 2024 compared to Q1 2023. The company also launched integrated predictive analytics and omnichannel engagement products, establishing a new category within the digital health ecosystem.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Healthcare Analytics market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption of Data-driven Decision Making in Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. Data Privacy and Security Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Software*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Services

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Descriptive Analytics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Predictive Analytics
  • 7.4. Prescriptive Analytics

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Financial Analytics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Clinical Analytics
  • 8.4. Operational Analytics
  • 8.5. Population Health Analytics
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Healthcare Providers*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Healthcare Payers (Insurance Companies)
  • 9.4. Pharmaceutical & Biotechnology Companies
  • 9.5. Government Organizations

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. IBM Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. SAS Institute Inc.
  • 12.3. McKesson Corporation
  • 12.4. HR Insights
  • 12.5. Siemens Healthineers
  • 12.6. Oracle Corporation
  • 12.7. Allscripts Healthcare Solutions, Inc.
  • 12.8. Philips Healthcare
  • 12.9. IQVIA
  • 12.10. Flatiron Health
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. Health Catalyst*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. Verisk Analytics
  • 12.13. OmniSYS
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us